Patient Information Leaflet and SmPC downloads

Adverse Events
Adverse events should be reported.

Reporting forms and information can be found at www.yellowcard.gov.uk.
Adverse events should also be reported to Morningside Helathcare Ltd.

Levest® is a monophasic combined oral contraceptive pill containing Levonorgestrel 150μg and Ethinylestradiol 30μg. Your patients may receive Levest® from their fertility clinic or from a pharmacy when prescriptions are written generically.

Please be reassured that your patients are still receiving reliable and effective contraceptive cover when they receive Levest®.

Levest® has been clinically tested and shown to be essentially similar to Microgynon® 30¹.

This website provides clinicians with further information about Levest® and its bioequivalence to
Microgynon® 30.

A range of patient information resources are also available to support patients receiving Levest® for the first time.